Information  X 
Enter a valid email address

Nuformix PLC Ord 0.1P (NFX)

Date Time Source Announcement
12 May 2021 11:35 am
RNS
Holding(s) in Company
11 May 2021 1:51 pm
RNS
Holding(s) in Company
22 Apr 2021 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
08 Apr 2021 3:30 pm
RNS
Correction: Holding(s) in Company
06 Apr 2021 10:38 am
RNS
Holding(s) in Company
30 Mar 2021 5:14 pm
RNS
Holding(s) in Company
29 Mar 2021 11:27 am
RNS
Result of General Meeting and Total Voting Rights
22 Mar 2021 7:00 am
RNS
NXP001 (Oncology) - Exercise of Option by Oxilio
19 Mar 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
11 Mar 2021 7:00 am
RNS
Initiation of research by Allenby Capital
10 Mar 2021 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Proposed Placing to raise �1.565 million
08 Mar 2021 12:00 pm
RNS
Holding(s) in Company
02 Mar 2021 7:00 am
RNS
Research Results
22 Feb 2021 3:45 pm
RNS
Holding(s) in Company
10 Feb 2021 7:00 am
RNS
Directorate Change
02 Feb 2021 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
22 Dec 2020 7:00 am
RNS
Appointment of Broker
  7:00 am
RNS
Half-year Report
07 Dec 2020 7:00 am
RNS
Appointment of Chief Executive Officer
02 Dec 2020 7:00 am
RNS
Appointment of Non-Executive Director
24 Nov 2020 7:00 am
RNS
Appointment of Non-Executive Director
09 Nov 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
26 Oct 2020 2:16 pm
RNS
Holding(s) in Company
22 Oct 2020 5:45 pm
RNS
Holding(s) in Company
  4:16 pm
RNS
Holding(s) in Company
07 Oct 2020 7:00 am
RNS
Placing and Strategic Update
24 Sep 2020 7:00 am
RNS
Exclusive Option Agreement for NXP001
20 Aug 2020 11:33 am
RNS
Result of AGM
19 Aug 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:24 pm
RNS
Results Pre-clinical Pilot Study in IPF for NXP004
28 Jul 2020 12:14 pm
RNS
Annual Report and Notice of AGM 2020
22 Jul 2020 7:00 am
RNS
Preliminary Results for year ended 31 March 2020
01 Jul 2020 11:15 am
RNS
Notification of Major Holdings
22 Jun 2020 7:00 am
RNS
Board Change
27 May 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Business Update
  7:00 am
RNS
Nuformix and VistaGen Announce CNS Agreement
06 May 2020 3:30 pm
RNS
Holding(s) in Company
03 Apr 2020 3:31 pm
RNS
Holding(s) in Company
30 Mar 2020 3:42 pm
RNS
Notiication of Major Share Holding
09 Mar 2020 4:42 pm
RNS
Second Price Monitoring Extn
  4:37 pm
RNS
Price Monitoring Extension
18 Feb 2020 7:00 am
RNS
Appointment of Dr Karl Keegan
14 Feb 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
13 Feb 2020 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
12 Feb 2020 4:10 pm
RNS
Notification of Major Holdings
05 Feb 2020 5:05 pm
RNS
Operational Update
  4:45 pm
RNS
Resignation of Dave Tapolczay
  2:24 pm
RNS
Director Dealing
  2:19 pm
RNS
Notification of Major Holdings
27 Jan 2020 7:00 am
RNS
Major Shareholding Notification
  7:00 am
RNS
Resignation of John Lidgey
15 Jan 2020 12:43 pm
RNS
Amendment to Notice
10 Jan 2020 11:45 am
RNS
Issue of Equity
08 Jan 2020 8:17 am
RNS
Holding(s) in Company
24 Dec 2019 7:00 am
RNS
Half-year Report
25 Nov 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Update and Placing Announcement
28 Oct 2019 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  8:30 am
RNS
Issue of Equity
25 Oct 2019 11:11 am
RNS
Statement re. Share Price Movement
  9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
20 Sep 2019 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
10 Sep 2019 4:49 pm
RNS
AGM Results
  7:00 am
RNS
Directorate Change
09 Sep 2019 7:00 am
RNS
Ebers Cannabinoid Collaboration Update
06 Sep 2019 7:30 am
RNS
Appointment of Dr Muhunthan Thillai
04 Sep 2019 7:30 am
RNS
Holding(s) in Company
01 Aug 2019 9:30 am
RNS
Annual Financial Report
29 Jul 2019 7:00 am
RNS
Holding(s) in Company
18 Jul 2019 7:00 am
RNS
Final Results
07 Jun 2019 7:00 am
RNS
Holding(s) in Company
06 Jun 2019 7:00 am
RNS
Holding(s) in Company
30 May 2019 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:01 am
RNS
Positive Results for NXP001 Clinical Trial
28 May 2019 7:00 am
RNS
Holding(s) in Company - Amendment
24 May 2019 7:30 am
RNS
Holding(s) in Company
  7:00 am
RNS
Loan Conversion
22 May 2019 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
15 May 2019 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Nuformix Achieves 2nd NXP001 Development Milestone
10 May 2019 9:00 am
RNS
Price Monitoring Extension
08 May 2019 7:30 am
RNS
Holding(s) in Company
09 Apr 2019 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Strategic Cannabinoid Agreement
05 Apr 2019 7:00 am
RNS
Notification Major Share Interests
22 Mar 2019 7:00 am
RNS
Nuformix Commences NXP001 Clinical Trial
27 Feb 2019 7:00 am
RNS
MHRA approval for NXP001
20 Feb 2019 6:16 pm
RNS
Holding(s) in Company
20 Dec 2018 7:00 am
RNS
Unaudited Half Year Results
03 Dec 2018 7:00 am
RNS
Reports Results from Novel IPF Pre-Clinical Trial
27 Nov 2018 7:00 am
RNS
Expansion of NXP001 Agreement & Milestone Payment
28 Sep 2018 10:09 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Additional New NXP002 Patent Filing
19 Sep 2018 2:33 pm
RNS
Result of AGM
14 Sep 2018 7:00 am
RNS
NXP001 Pre-Clinical Milestone Achieved
28 Aug 2018 12:55 pm
RNS
Convertible Loan Amendment
16 Aug 2018 7:00 am
RNS
Annual Report and Notice of AGM
26 Jul 2018 2:00 pm
RNS
Final Results
09 Jul 2018 9:33 am
RNS
Holding(s) in Company
02 Jul 2018 7:00 am
RNS
Operational Update
26 Jun 2018 8:00 am
RNS
Collaboration with SGSC
11 May 2018 7:00 am
RNS
Dr Chris Blackwell Appointed NED
24 Apr 2018 11:54 am
RNS
Holding(s) in Company
11 Apr 2018 4:41 pm
RNS
Stmnt re Share Price Movement
02 Mar 2018 1:30 pm
RNS
Update re: Broker
27 Feb 2018 9:37 am
RNS
Holding(s) in Company
31 Jan 2018 7:00 am
RNS
NXP002 Pilot Study in Lung and Liver Fibrosis
15 Dec 2017 7:30 am
RNS
Agreement to License NXP001
14 Dec 2017 7:00 am
RNS
Dr Andy Richards Chairs Advisory Panel - New Appts
12 Dec 2017 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
06 Dec 2017 7:00 am
RNS
Grant of Warrants
01 Dec 2017 7:30 am
RNS
Appointment of Broker
10 Nov 2017 10:19 am
RNS
Holding(s) in Company
01 Nov 2017 12:23 pm
RNS
Holding(s) in Company
23 Oct 2017 7:30 am
RNS
Holding(s) in Company
19 Oct 2017 7:00 am
RNS
NXP001 agreement for pilot bioequivalence study
16 Oct 2017 7:00 am
RNS
Admission and First Dealings
  7:00 am
RNS
Cancellation Notice and Re-Admission
13 Oct 2017 3:44 pm
RNS
Change of Name
  12:35 pm
RNS
Result of Meeting and Completion of Acquisition
  7:00 am
RNS
Half-year Report
22 Sep 2017 7:00 am
RNS
Final Results and Annual Report
15 Sep 2017 2:15 pm
RNS
Prospectus re: Proposed Acquisition of Nuformix
20 Apr 2017 7:00 am
RNS
Convertible Loan Agreement
23 Dec 2016 7:00 am
RNS
Half-year Report
21 Sep 2016 7:00 am
RNS
Accounts for the period ended 31 March 2016
  7:00 am
RNS
New Accounting Ref Date
16 Sep 2016 1:03 pm
RNS
Possible Acquisition and Suspension of Trading
29 Mar 2016 7:00 am
RNS
Half Yearly Report
24 Feb 2016 7:00 am
RNS
Broker Appointment and Corporate Update
17 Dec 2015 7:00 am
RNS
Publication of Prospectus and First Dealings
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t